Mouse Models of Diabetes, Obesity and Related Kidney Disease

scientific article

Mouse Models of Diabetes, Obesity and Related Kidney Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2016PLoSO..1162131G
P356DOI10.1371/JOURNAL.PONE.0162131
P932PMC publication ID5006968
P698PubMed publication ID27579698

P50authorSarah J. GlastrasQ51694443
Hui ChenQ41044744
Rachel T McGrathQ43228926
P2093author name stringJason Chen
Muh Geot Wong
Carol A Pollock
Sonia Saad
Rachel Teh
P2860cites workObesity-Related Chronic Kidney Disease-The Role of Lipid MetabolismQ26774143
Lessons from mouse models of high-fat diet-induced NAFLDQ26829532
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreasQ28217509
Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathwayQ28509217
A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1Q28543256
Prevalence of chronic kidney disease in the United StatesQ29614191
Obesity-related glomerulopathy: an emerging epidemicQ34190647
The use of animal models in diabetes researchQ34255921
Chronic kidney disease: global dimension and perspectivesQ34347984
Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspectiveQ34503601
Diabetes mellitus: The epidemic of the centuryQ34671155
Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesityQ34979668
Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stressQ35126070
Dysplastic hepatocytes develop nuclear inclusions in a mouse model of viral hepatitisQ35188743
C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis.Q51570758
Nongenetic mouse models of non-insulin-dependent diabetes mellitus.Q54134954
Receiver operating characteristic analysis of glycogenated nuclei in liver biopsy specimens: quantitative evaluation of their relationship with diabetes and obesityQ72719983
Influence of long-term diabetes on renal glycogen metabolism in the ratQ73431013
Beraprost sodium, a stable prostacyclin analogue, improves insulin resistance in high-fat diet-induced obese miceQ83769966
Challenges of chronic kidney disease preventionQ87241606
Protein aggregation in recombinant bacteria: biological role of inclusion bodies.Q35545575
Development of a nongenetic mouse model of type 2 diabetesQ35580004
Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohortQ35666503
Obesity, metabolic health, and the risk of end-stage renal diseaseQ35667706
Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney diseaseQ35739217
Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristicsQ35781864
FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity.Q36294501
Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal ObesityQ36719266
Animal models of obesityQ36742593
Histopathology of diabetic nephropathyQ36785588
Rodent models of streptozotocin-induced diabetic nephropathyQ36820026
High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice.Q36937909
Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c.Q36956072
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusQ37141727
The modern spectrum of renal biopsy findings in patients with diabetesQ37212364
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathyQ37603244
Obesity Related Kidney DiseaseQ37808494
Direct and indirect effects of obesity on the kidneyQ38084514
Obesity-related glomerulopathy and the nephron complementQ38122630
Diabetic kidney disease: a report from an ADA Consensus Conference.Q38254458
Experimental diabetes induced by alloxan and streptozotocin: The current state of the art.Q38644013
Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injuryQ42186397
Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesionsQ42932026
Structural and functional changes in the kidneys of high-fat diet-induced obese miceQ46275989
Evaluating the glucose tolerance test in miceQ46350758
Glycogen accumulation in renal tubules, a key morphological change in the diabetic rat kidneyQ46535863
Mouse Models for Studying Diabetic NephropathyQ46715584
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectobesityQ12174
P304page(s)e0162131
P577publication date2016-08-31
P1433published inPLOS OneQ564954
P1476titleMouse Models of Diabetes, Obesity and Related Kidney Disease
P478volume11

Reverse relations

cites work (P2860)
Q47797046Adenine-induced chronic kidney disease in rats
Q91755491Amelioration of Endoplasmic Reticulum Stress by Mesenchymal Stem Cells via Hepatocyte Growth Factor/c-Met Signaling in Obesity-Associated Kidney Injury
Q47548477Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Leprdb mice
Q55456375Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus.
Q52608853Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain.
Q41034789Effect of synergistic interaction between abnormal adiposity-related metabolism and prediabetes on microalbuminuria in the general population
Q41072417Effects of high-intensity interval versus mild-intensity endurance training on metabolic phenotype and corticosterone response in rats fed a high-fat or control diet
Q41320071Green Tea Polyphenols Ameliorate the Early Renal Damage Induced by a High-Fat Diet via Ketogenesis/SIRT3 Pathway
Q47179983Inactivation of SPAK kinase reduces body weight gain in mice fed a High-fat diet by improving energy expenditure and insulin sensitivity
Q96680410Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents
Q58699037Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia
Q50421794Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring
Q90395699Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
Q64318064Potential use of transgenic domestic pigs expressing recombinant human erythropoietin in diabetes translation research
Q90564083Resveratrol Protects Against Renal Damage via Attenuation of Inflammation and Oxidative Stress in High-Fat-Diet-Induced Obese Mice
Q64116871Synergistic Hypoglycemic Effects of Pumpkin Polysaccharides and Puerarin on Type II Diabetes Mellitus Mice
Q96306423Temporal pressure enhanced topical drug delivery through micropore formation
Q88215222The Influence of Obesity on the Pharmacokinetics of Dioxin in Mice: An Assessment Using Classical and PBPK Modeling
Q50421864Timing of host feeding drives rhythms in parasite replication
Q47693328Trigonelline Inhibits Inflammation and Protects β Cells to Prevent Fetal Growth Restriction during Pregnancy in a Mouse Model of Diabetes

Search more.